The role of oxidized high-density lipoprotein (oxHDL) and the protective effects of adiponectin in terms of vascular calcification is not well-established. This study was conducted to investigate the effects of oxHDL with regard to inflammation and vascular calcification and to determine the protective role of adiponectin in attenuating the detrimental effects of oxHDL. Cell viability, mineralization, and calcification assays were conducted to optimize the concentration of oxHDL. Then, human vascular smooth muscle cells (HAoVSMCs)
Inflammation and Vascular Calcification Causing Effects of
, Suhaila Abd Muid 1,3 important event occurring during the advanced atherosclerosis stage (1) . This plaque formation will lead to the formation of thrombotic occlusion which will narrow the blood vessel. The plaque would become unstable and rupture may occur; the blood flow to the brain or heart can be blocked; causing stroke or an infarct (2) . Vascular calcification is a major risk factor for coronary artery disease and a major cause of death in patients with chronic kidney failure (3) . It is believed to be initiated by transdifferentiation of vascular smooth muscle cells 
Materials and methods

Cell Culture
Primary adult human aortic vascular smooth muscle cells, HAoVSMCs (Lot no: 400Z012.2;
Promocell, USA) was used in this present study. and 100 g/ml protein).
The mineralization assay was performed according to previous study (12) . Briefly, the While for the transcription factor, NF-ĸβ (p65), nuclear extracts were used and extracted by nuclear extraction kit (Cayman Chemical, USA).
Statistical analysis
Data were analysed using SPSS version 21.0.
ANOVA test was performed to assess overall differences between the different groups of treatment followed by Bonferroni Post-HOC test.
Significant value was set at P <0.05.
Results
Non-toxic concentrations of oxHDL and adiponectin
The MTS test was performed to determine the non-toxic concentration range of oxHDL and adiponectin for further analysis. Figure 1 shows the range of concentrations used for both oxHDL (A) and adiponectin (B). OxHDL at 10-100 μg/ml protein exhibited a cell viability above 95 %.
Adiponectin concentrations ranging from 2.5-15
μg/ml maintained a cell viability above 95 %. The addition of β-glycerophosphate generate high phosphorus environment in the medium, which is important for hydroxyapatite crystal formation.
This phosphorous also induces the ALP activity, core binding factor α 1 (Cbfα1) gene expression, mineral nodules formation and calcium deposition in VSMCs, which mimic in vitro mineralization by osteoblasts (14) .
In addition, incubation with 100 μg/ml protein oxHDL showed a significant calcium deposition in comparison with unstimulated group (P <0.0001) which was concurrent with the mineralization assay ( Figure 3) . Therefore, the concentration of 100 μg/ml oxHDL was selected for further studies measuring the protein expression of proinflammatory and osteogenic biomarkers.
Effects of oxHDL and adiponectin on the secretion of the pro-inflammatory cytokines IL-6 and TNF-a
Elevation of pro-inflammatory cytokine secretion is known as one of the factors that heightens the progression of atherosclerosis. In this study, oxHDL significantly increased the secretion In contrast to the effect on IL-6 expression, oxHDL showed a non-significant increase of TNF- 5 cells/well were treated for 24 h with β-glycerophosphate (positive controls), culture medium (un-stimulated, negative control), HDL (100 μg/ml), oxHDL (100 μg/ml), adiponectin (5, 10 and 15 μg/ml), and combination of oxHDL (100 μg/ml) with adiponectin (5, 10 and 15 μg/ml). The cell supernatant was collected and used for soluble protein expression by ELISA Data are expressed as mean SEM of 3 experiments. *P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001, ****P≤0. , culture media (unstimulated, negative control), 100 μg/ml protein HDL, 100 μg/ml protein oxHDL, 5, 10 and 15 μg/ml adiponectin, and combination between 100 μg/ml oxHDL with 5, 10 and 15 μg/ml adiponectin. The cell supernatant was collected and used for protein detection by specific ELISA kits. The results shown in mean  SEM of 3 experiments. *p≤0.05, **p≤0.01, ***p≤0.001, ****p≤0.0001. *indicates the comparison with oxHDL group, #indicates the comparison with un-stimulated group. 5 cells/well were treated for 24 h with β-glycerophosphate (positive control), media (un-stimulated, negative control), 100 μg/ml HDL, 100 μg/ml oxHDL, 5, 10 and 15 μg/ml adiponectin, and combination of 100 μg/ml oxHDL with 5, 10 and 15 μg/ml adiponectin. The cytosolic protein was extracted using AllPrep® RNA/Protein kit (Qiagen) and was quantified by using specific ELISA kit. The results are shown as meanSEM of 3 experiments. *P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001, and **** P≤ 0.0001. *indicates the comparison with oxHDL group, # indicates the comparison with unstimulated group. 
About 3x10
5 cells/well were treated for 24 h with β-glycerophosphate (positive control), media (un-stimulated, negative control), 100 μg/ml HDL, 100 μg/ml oxHDL, 5, 10 and 15 μg/ml adiponectin, and combination of 100 μg/ml oxHDL with 5, 10 and 15 μg/ml adiponectin. The targeted protein of WNT-5a, cAMP, STAT-3 and NF-ĸβ (p65) were quantified by using specific ELISA kit. The results are shown as meanSEM of 3 experiments. *P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001, and ****P≤ 0.0001. *indicates the comparison with oxHDL group, Inflammation, caused by oxHDL, in this study elevated the secretion of WNT-5a in HAoVSMCs.
IL-6 was shown to initiate the secretion of WNT-5a in melanoma cells and human bone marrow stromal cells, respectively (21, 22) . High secretion of WNT5a is one of the indicators of the severity of atherosclerotic progression as it was found to be higher in advanced atherosclerotic plaque regions (23) . It was also reported that the serum of atherosclerotic patients usually contains higher WNT-5a protein than normal individuals (23).
Interestingly, WNT-5a is also involved in inducing vascular calcification of smooth muscle cells through the non-canonical WNT-5a/ROR2
signaling pathway which supports our findings (23, 24) . Furthermore, oxLDL which is a very well- 6/WNT-5a/NF-ĸβ (p65)/osterix. 
